About
TT3A is an innovative Italy-based MedTech startup pioneering the development of the world's first medical device specifically designed for the endovascular treatment of ascending aortic aneurysms and dissections. Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and safety, setting the stage for transformative solutions in aortic care.
Technologies
GmailGoogle AppsApacheMobile Friendly
Keywords
medical equipment manufacturingeuropean regional development fundendovascular prosthesismedical deviceinnovative medical deviceinvestment fundingrecovery time reductionaortic pathologiesrevolutionary aortology devicepatient outcomesataads treatmentpercutaneous approachminimally invasive treatmentadvanced device designendovascular therapydevice developmentfully transcatheter devicemedical devicespercutaneous repairtranscatheter treatmenttranscatheter aortic repairregional co-financingfeasibility studiesbiotechnologymedical innovationhealthcarepatient safetyinnovative prosthesisrisk assessmentdevice design
Company Information
- Employees4
- Founded2022
Location
Viale Ortles, Milan, Lombardy, Italy, 20139
